Schwab Andrew J.

Schwab Andrew J. is listed in filings as Director at Skye Bioscience, Inc.. This profile follows SEC Form 4 activity through Apr 2, 2026, including sale activity. Recent filings connect the profile to Skye Bioscience, Inc. (SKYE) and CAMP4 Therapeutics Corporation (CAMP). The current snapshot covers public activity from Sep 13, 2024 to Apr 2, 2026. Reported amounts are shown as $46.1K to $4.5M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.